Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001209191-23-036465

Chief Financial Officer acquired 5,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2023-06-09 Option exercise +5,800 $2.08 $12,064 154,270 D
Derivatives
Cummings Keith Lamont Chief Financial Officer 2023-06-09 Option exercise · Stock Option (Right to Buy) −5,800 127,797 D
Loading xslF345X04/doc4.xml…